Endocrinology Medical News about Graves Hyperthyroidism

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Graves Hyperthyroidism after Stopping Immune Suppressive Therapy in Type 1 Diabetic Islet Cell Recipients with Pretransplant TPO-Autoantibodies
Diabetes Care, 07/02/09

Keymeulen B et al. - Type 1 diabetic recipients of islet cell grafts with pretransplant TPO-autoantibody positivity exhibit a high risk for developing Graves' hyperthyroidism after immune suppressive therapy is discontinued for a failing graft.

<< Previous
Ketoacidosis at diabetes onset is still frequent in children and...

Next >>
Endothelial markers may link kidney function to cardiovascular...

Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves' Hyperthyroidism
JACC - Journal of the American College of Cardiology, 10/05/09 Relevance Score: 68%

Graves' Disease Associated with Primary Systemic Sclerosis
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09 Relevance Score: 65%

Recurrence of Graves' Disease in Thyroglossal Duct Remnants: Relapse After Total Thyroidectomy
Thyroid, 11/19/09 Relevance Score: 44%

Herpes virus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease
European Journal of Endocrinology, 11/19/09 Relevance Score: 43%

Premature hair greying may predict reduced bone mineral density in Graves' disease
Irish Journal of Medical Science, 10/27/09 Relevance Score: 43%